免疫瘤学在生殖尿道癌症方面的进展
Peter D Zang1, Arkhjamil Angeles2, Tanya B Dorff1
1Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA.
概括
免疫瘤学 (IO) 已经推进了生殖尿道癌症的治疗,成为转移性细胞癌的标准治疗. 本综述涵盖了尿道,前列腺和其他泌尿器癌的IO进展和挑战,探索了超越检查点抑制的新疗法.
科学领域:
- 泌尿生殖瘤学 泌尿生殖瘤学
- 免疫疗法研究 免疫疗法研究
- 癌症治疗的进步 癌症治疗的进步
背景情况:
- 在过去的十年中,免疫瘤学 (IO) 显著影响了生殖尿道 (GU) 癌症的治疗.
- 取得了显著的进展,IO已成为转移性细胞癌的标准护理前线治疗.
- 在优化IO在各种GU恶性瘤中的初始应用方面仍然存在挑战.
研究的目的:
- 审查最近的免疫瘤学对生殖尿道癌症的进展.
- 讨论GU免疫瘤学的挑战和未来方向.
主要方法:
- 关于免疫瘤学在生殖尿道恶性瘤中的应用的文献综述.
- 分析当前的标准护理疗法和新兴治疗策略.
主要成果:
- 免疫瘤现在是转移性细胞癌的标准前线治疗.
- 在尿路癌中IO的使用越来越多,有希望的新疗法.
- 在前列腺癌,生殖细胞瘤和阴茎癌中IO的挑战和局限性.
结论:
- 免疫瘤学彻底改变了泌尿生殖系统癌症的治疗方法,特别是在细胞癌中.
- 对IO的持续研究,包括新的方法,对于改善其他生殖尿道癌症的结果至关重要.
- 未来的方向包括探索肠道微生物组和T细胞重定向以提高疗效.
相关概念视频
Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527
Cancer Vaccines
368
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
368
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K


